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1. Experimental details 
 
Extraction, collection of glycoproteins from porcine bladder urothelial tissue 
Bladders were obtained from an abattoir near York (A Traves & Son Ltd.)  and processed the morning   Ǥ         ǯ  
solution (HBSS), containing calcium and magnesium, supplemented with HEPES buffer solution 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (5 mL in 500 mL HBSS), 20 KIU aprotinin (1 mL in 500 
mL), Fungizone (2 mL in 500 mL to give a final concentration of 1 µg/mL) and Pen-Strep (5 mL in 500 
mL to give a final concentration of 100 µg/mL). 
 
Urothelium was removed from dissected bladders by surface scraping using a scalpel (protocol 
validated by C-Y Wang (personal communication). The urothelial scrapings were then washed in HBSS 
medium and centrifuged. The medium was removed and the cell pellet was re-suspended in 750 µL 
HBSS medium. Aliquots of ~50 µL of cell suspensions were transferred into microfuge tubes (each 
aliquot around 50 mg), centrifuged and the supernatant was removed and samples were stored at -80 
°C until needed. 
 
Cell culture 
hTERT mesenchymal stromal cell (MSC) culture 
hTERT MSCs are immortalized cell lines generated from primary human mesenchymal stromal cells 
by lentiviral transduction with a human telomerase gene and subsequent single cell cloning45. Cells    ǯ    ȋ ǡ ǡ  Ȍ
supplemented with 10 % fetal bovine serum, 1 % Penicillin/streptomycin and 1 % Gluta-Max-I. 
Cultures were grown in a humidified incubator at 37 °C in 5 % CO2 in air in 10 cm Petri dishes and 
harvested at around 80 % confluency.  
 
One-sample, one-pot protocol 
MSC harvest. 
A 10 cm dish of MSC cells, just under confluency, was washed gently with warm phosphate buffered 
saline (PBS) six times. Cells were then scraped with a cell scraper and with 1 mL PBS into a plastic Ǥ ? ? ? ? ?ǡ ?ǡ ?ǏǤ discarded and 
the cells were ready for lysis. 
 
Cell lysis/glycoprotein sample preparation. using an adapted enhanced filter-aided sample 
preparation (eFASP)36 protocol 
20 pmol of porcine stomach mucin (Sigma Aldrich, UK) was solubilised in 10 µL eFASP lysis buffer36 (4 
% SDS, 0.2 % deoxycholic acid (DCA), 50 mM Tris(2-carboxyethyl) phosphine hydrochloride (TCEP), 
100 mM ammonium bicarbonate, pH 8). (For urothelial and MSC samples, eFASP lysis buffer was 
added at 10 x volume of the cell pellet). Samples were heated at 90 °C for 10 min. The sample was 
vortexed to mix and cooled to 37 °C before adding the alkylation stock solution (500 mM 4-
 3 
vinylpyridine in ethanol) to give a final concentration of 25 mM 4-vinylpyridine. The sample was 
incubated at 37 °C, 15 min. Quench buffer (1 M dithiothreitol, 100 mM ammonium bicarbonate, pH 8) 
was added to give a final concentration of 40 mM DTT. The glycoprotein sample was diluted with 
exchange buffer (8 M urea, 100 mM ammonium bicarbonate, with or without 0.2 % DCA) solution in 
either 10:1 or 40:1 ratio of exchange buffer to sample solution by volume. An aliquot of up to 450 µL of 
the resulting solution was transferred to a filter unit (Amicon® Ultra-0.5 centrifugal filter unit, 
nominal mass cut off 30 kDa), centrifuged for 5 min, and the filtrate discarded. This was repeated until 
all the sample solution had passed through the filter membrane. The sample retained above the filter 
membrane was rinsed three times with 300 µL of exchange buffer (centrifuging after each rinse for 5 
min), and the filtrate was discarded. The filter was then rinsed three times with 50 mM ammonium 
bicarbonate (centrifuging after each rinse for 5 min), and the filtrate was discarded. The filter unit was 
transferred to a clean collection tube ready for N- or O-glycan release. 
 
Ⱦ-elimination Ȃ using overnight incubation 
300 µL NH4OH solution (28-30%) (Sigma-Aldrich, UK) was added to the filter device containing the 
glycoprotein sample remaining in the filter unit after the solubilisation and washing steps. The 
glycoprotein sample was incubated in NH4ǡ   ? ?Ǐ   ? ?     Ǥ 	
incubation, the filter device was centrifuged for 5 min at 14000 x g. 150 µL water was added to the 
filter device and then centrifuged for a further 5 min. This was repeated once. The filtrates containing 
the released O-glycans were all collected in the same tube and were transferred to a glass tube and 
dried using a vacuum centrifuge, ready for permethylation.  The filter unit was transferred to a clean 
collection tube ready for N-glycan release. 
 
Ⱦ-elimination Ȃ using sonication 
300 µL NH4OH solution (28-30%) (Sigma-Aldrich, UK) was added to the filter device containing the 
glycoprotein sample remaining in the filter unit after the solubilisation and washing steps. The sample  ? ?Ǐ ? ? ?Ǐ ? ?ǡ
followed by another 5 min of sonication. The sonication/rest cycle was repeated giving a total 
sonication time of 20 min and total intervening rest time of 40 min. The filter device was centrifuged 
for 5 min at 14000 x g. 150 µL water was added to the filter device and then centrifuged for a further 5 
min. This was repeated once. The filtrate was then transferred to a glass tube and dried using a 
vacuum centrifuge, ready for permethylation. The filter unit was transferred to a clean collection tube 
ready for N-glycan release. 
 
Ⱦ-elimination Ȃ using microwave irradiation 
300 µL NH4OH solution (28-30%) (Sigma-Aldrich, UK) was added to the filter device containing the 
glycoprotein sample remaining in the filter unit after the solubilisation and washing steps and gently 
pipetted to mix. The glycoprotein sample was transferred to a microwave reactor tube and irradiated 
with microwaves for 10 min, at 20 W, at 45 ǏC, in a CEM discover microwave reactor. Following 
microwave irradiation, the sample was transferred to a clean filter unit and centrifuged for 5 min at 
14000 x g. 150 µL water was added to the filter device and then centrifuged for a further 5 min. This 
was repeated once. The filtrates containing the released O-glycans were all collected in the same tube 
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and were transferred to a glass tube and dried using a vacuum centrifuge, ready for permethylation.  
The filter unit was transferred to a clean collection tube ready for N-glycan release. 
 
 
PNGase F treatment Ȃ N-glycan release 
100 µL of 50 mM ammonium bicarbonate solution pH 8 was added to the filter unit, followed by 8 U (4 
µL of a 2 U/µL solution in 5 mM potassium phosphate, pH 7.5) of PNGase F. The sample was incubated 
at 37 °C for 16 h in a heating block. Following incubation, the filter device was centrifuged for 5 min at 
14000 x g. 150 µL water was added to the filter device and then centrifuged for a further 5 min. This 
was repeated once. The filtrates containing the released N-glycans were all collected in the same tube 
and transferred to a glass tube and dried using a vacuum centrifuge, ready for permethylation. The 
filter unit was transferred to a clean collection tube ready for tryptic digestion of the protein 
remaining above the filter membrane. 
 
Note: the one pot method can also be carried out by releasing N-glycans first. 
 
Tryptic digestion 
The protein remaining in the filter unit following N- and O-glycan release was treated with trypsin at 
37 °C for 16 h. Following incubation the filter was centrifuged to collect the tryptic peptides. Samples 
were acidified with 0.1 % TFA before LC-MS/MS analysis. 
 
Permethylation 
The dried released glycans were re-dissolved in approx. 1 mL DMSO (Sigma Aldrich, UK). 
Approximately 20 mg of NaOH powder was added, immediately followed by 150 µL, dropwise, of 
iodomethane (Sigma Aldrich, UK) and the solution was left to stand for 10 min. A further 150 µL of 
iodomethane was added dropwise and the solution was left to stand for 10 min. A final 300 µL of 
iodomethane was added dropwise to the sample solution and left to stand for 20 min. The reaction 
was quenched by addition of 1 mL of 100 mg/mL sodium thiosulfate solution, when 1 mL 
dichloromethane (DCM) was added and the sample solution was mixed using a vortex mixer. The 
solution was left to stand until the organic/aqueous layers had separated and then the (upper) 
aqueous layer was removed. The organic layer was washed with about 1 mL water a total of five times, 
finally removing the aqueous layer and drying the organic layer in a vacuum centrifuge.  
 
The internal standard, maltotetraose, was deutero-permethylated using iodomethane-d3, following 
the same procedure outlined for permethylation. A stock solution of 400 pmol was prepared and the 
deutero-permethylated maltotetraose was spiked into the permethylated glycan samples to 4 pmol 
prior to spotting on the MALDI target plate. 
 
 
 
 
Mass spectrometry/analysis details 
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MALDI-MS 
The dried permethylated glycans were re-dissolved in 10 µL acetonitrile.  The matrix was prepared by 
dissolving 2,5-dihydrobenzoic acid in 50 % aqueous acetonitrile, giving a 20 mg/mL solution. The 
sample spot was prepared by mixing 4 µL of the matrix solution with 2 µL sample solution. 2 µL of the 
mixture was transferred to a stainless steel MALDI target plate and dried under vacuum. 
 
Mass spectra were acquired on a Fourier-transform ion cyclotron resonance (FT-ICR) mass 
spectrometer. A 9.4 T solariX FT mass spectrometer (Bruker Daltonics), with a smartbeam-II ? laser 
was operated in positive ion mode MALDI. The mass spectrometer was calibrated externally using a 
permethylated maltoheptaose standard. Mass spectra were recorded over an m/z range 400-4000, 
acquiring 12 scans, with each scan being derived from 500 laser shots. The laser power was set at 40 
%. Spectra were acquired using ftmscontrol software (2.0) and processed with DataAnalysis 4.0. 
 
Glycan analysis 
Relative abundance of glycans was calculated by calculating each glycan MS signal as a percentage of 
the spiked internal standard signal. Statistical analysis was carried out using a one-way ANOVA with 
Holm Sidak post-hoc test (* for P = < 0.05, ** for P = < 0.01 and *** for P = < 0.0001). 
 
Tandem mass spectrometry 
Product ion spectra were acquired using a Nanospray Flex ion source with off-line borosilicate 
emitters on an Orbitrap Fusion hybrid mass spectrometer (Thermo Scientific). Positive ESI-MS and 
MS2 product ion spectra were acquired in the Orbitrap using Xcalibur software (version 4.0, Thermo 
Scientific). Fragmentation was induced using either collision induced dissociation (CID) or higher 
energy collision dissociation (HCD). For CID, collision energy was varied between 25-35 %, and for 
HCD the collision energy was varied between 32-43 %, depending on the m/z of the glycans, and the 
quadrupole isolation window set to 2 m/z units. 
 
Peptide analysis 
Samples were loaded onto an UltiMate 3000 RSLCnano HPLC system (Thermo Scientific) equipped 
with a PepMap 100 Å C18, 5 µm trap column (300 µm x 5 mm Thermo Scientific) and an Acclaim 
PepMap RSLC, 2 µm, 100 Å, C18 RSLC nanocapillary column (75 Pm x 150 mm, Thermo Scientific). The 
trap wash solvent was 0.05 % (v/v) aqueous trifluoroacetic acid and the trapping flow rate was 15 
µL/min. The trap was washed for 3 min before switching flow to the capillary column.  The separation 
used a gradient elution of two solvents (solvent A: aqueous 2 % (v/v) acetonitrile containing 1 % 
(v/v) formic acid; solvent B: acetonitrile containing 1 % (v/v) formic acid). The flow rate for the 
capillary column was 300 nL/min. Column temperature was 50°C and the gradient profile was: linear 
3-10 % B over 7 min, linear 10-35 % B over 30 min, linear 35-99 % B over 5 min then proceeded to 
wash with 99 % solvent B for 4 min. The column was returned to initial conditions and re-equilibrated 
for 15 min before subsequent injections. 
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The nanoLC system was interfaced with an Orbitrap Fusion hybrid mass spectrometer (Thermo) with 
a Nanospray Flex ionisation source (Thermo). Positive ESI-MS and MS2 product ion spectra were 
acquired using Xcalibur software (version 4.0, Thermo). Instrument source settings were: ion spray 
voltage, 2,200 V; sweep gas, 2 Arb; ion transfer tube temperature; 275 °C. Mass spectra were acquired 
in the Orbitrap with: 120,000 resolution, scan range: m/z 375-1,500; AGC target, 4e5; max fill time, 
100 ms; data type, profile. MS2 product ion spectra were acquired in the linear ion trap specifying: 
quadrupole isolation, isolation window, m/z 1.6; activation type, HCD; collision energy, 32%; scan 
range, normal; scan rate, rapid; first mass, m/z 110; AGC target, 5e3; max injection time, 100 ms; data 
type, centroid.  Data dependent acquisition was performed in top speed mode using a 3 s cycle.  
Dynamic exclusion was performed for 50 s post precursor selection and a minimum threshold for 
fragmentation was set at 5e3. 
 
Protein identification 
Peak lists were generated in MGF format using Mascot Distiller (version 5, Matrix Science), stipulating 
a minimum signal to noise ratio of 2 and correlation (Rho) of 0.6. MGF files were searched against the 
porcine subset of the UniProt database (34,316 sequences; 14,316,901 residues), with a decoy 
database, using a locally-running copy of the Mascot program (Matrix Science Ltd., version 2.5.1). 
Search criteria specified: enzyme, trypsin; fixed modifications, pyridylethyl (C); variable modifications, 
deamidated (NQ), oxidation (M), ser->diamino-propanoate (S), thr->Dab (T), Thr-> diamino-butyrate 
(T); peptide tolerance, +/- 5 ppm; MS/MS tolerance, 0.5 Da; Instrument, ESI-TRAP.  Results were 
passed through Mascot percolator to achieve a false discovery rate of <1% and further filtered to 
accept only peptides with an expect score of 0.05 or lower. 
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2. Additional experimental data 
 
 
 
Figure S- 1. MALDI-FT-ICR spectrum of permethylated O-glycans, ionised as [M + Na]+, 
released from porcine stomach mucin a) following FASP for SDS removal/exchange, b) 
following eFASP for SDS removal/exchange. Both followed by O-glycan release, in the filter 
using NH4OH. Note glycans displayed are the composition only. Other isomers are 
possible. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 8 
 
Table S- 1: Mass accuracies for porcine stomach mucin O-glycans 
Observed m/z Calculated 
m/z 
Mass accuracy 
(ppm) 
O-glycan 
composition 
518.257 518.2572 0.39 Hex1HexNAc1 
692.346 692.3464 0.58 Hex1HexNAc1Fuc1 
763.383 763.3835 0.65 Hex1HexNAc2 
896.443 896.4462 3.57 Hex2HexNAc1Fuc1 
937.473 937.4727 -0.32 Hex1HexNAc2Fuc1 
967.484 967.4833 
-0.72 Hex 2HexNAc2 
1141.572 1141.5725 
0.44 
Hex2HexNAc2Fuc1 
1212.610 1212.6096 -0.33 Hex2HexNAc3 
1315.662 1315.6617 -0.23 Hex2HexNAc2Fuc2 
1345.673 1345.6723 -0.52 Hex3HexNAc2Fuc1 
1386.699 1386.6988 -0.14 Hex2HexNAc3Fuc1 
1416.710 1416.7094 -0.42 Hex3HexNAc3 
1457.736 1457.7359 -0.07 Hex2HexNAc4 
1519.761 1519.7615 0.33 Hex3Hex NAc2Fuc2 
1560.788 1560.7880 0.00 Hex3Hex NAc3Fuc1 
1590.799 1590.7986 -0.25 Hex2Hex NAc4Fuc1 
1631.826 1631.8251 -0.55 Hex3Hex NAc4 
1661.837 1661.8357 -0.78 Hex3HexNAc3Fuc2 
1764.890 1764.8878 -1.25 Hex3HexNAc4Fuc1 
1835.925 1835.9249 
-0.05 Hex3HexNAc3Fuc1 
1865.933 1865.9355 
1.34 
Hex4HexNAc4 
1906.965 1906.9620 -1.57 Hex3HexNAc5 
1968.987 1968.9876 0.30 Hex4HexNAc3Fuc2 
2010.015 2010.0141 -0.45 Hex3HexNAc4Fuc2 
2040.023 2040.0247 0.83 Hex4HexNAc4Fuc1 
2081.052 2081.0512 -0.38 Hex3HexNAc5Fuc1 
2214.113 2214.1139 0.41 Hex4HexNAc4Fuc2 
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Figure S- 2.  MALDI-FT-ICR spectrum (m/z 1200-2220) of permethylated O-glycans, 
ionised as [M + Na]+, released from mucin. a) alkylation using 4-vinylpyridine for 1 h, b) 
alkylation using iodoacetamide for 1 h, c)  alkylation using 4-vinylpyridine for 15 min, d) 
alkylation using iodoacetamide for 15 min. Glycans displayed illustrate composition only. 
Other isomers are possible. 
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Figure S- 3. MALDI-FT-ICR mass spectrum of permethylated O-glycans released from 
porcine stomach mucin, ionised as [M + Na]+, using 16 h incubation (top panel), 5 min 
sonication/10 min rest (x4) (middle panel) and 10 min microwave irradiation (bottom 
panel). Glycans displayed illustrate the composition only. Other isomers will be possible. 
Table S- 2: Mass accuracies of O-glycans identified in porcine urothelial cells. 
Observed m/z Calculated 
m/z 
Mass accuracy 
(ppm) 
O-glycan 
composition 
518.257 518.2572 0.39 Hex1HexNAc1 
692.346 692.3464 0.58 Hex1HexNAc1Fuc1 
722.357 722.3569 -0.14 Hex2HexNAc1 
879.430 879.4304 0.45 NeuAc1Hex1HexNAc1 
896.443 896.4462 3.57 Hex2HexNAc1Fuc1 
937.476 937.4727 3.77 Hex1HexNAc2Fuc1 
967.483 967.4833 
0.31 Hex2HexNAc2 
1083.530 1083.5306 0.55 NeuAc1Hex2HexNAc1 
1124.556 1124.5572 1.07 NeuAc1Hex1HexNAc1 
1141.571 1141.5725 
1.31 
Gal2GalNAc2Fuc1 
1154.657 1154.6577 0.61 NeuGc1Hex1HexNAc2 
1171.582 1171.5831 0.94 Hex3HexNAc2 
1328.656 1328.6569 0.68 NeuAc1Hex2HexNAc2 
1358.668 1358.6675 -0.37 NeuGc1Hex2HexNAc2 
1485.733 1485.7308 -1.48 NeuAc2Hex1HexNAc2 
1573.784 1573.7833 -0.44 NeuAc1Hex2HexNAc3 
1777.883 1777.8830 0.00 NeuAc1Hex3HexNAc3 
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Figure S- 4. HCD spectra of precursor m/z 967, [M + Na]+ from porcine urothelial N-glycans 
(top) and O-glycans (bottom). 
 
 
 
 
 
 
  
200 250 300 350 400 450 500 550 600 650 700 750 800 850 900 950 
0 
5 
10 
15 
20 
25 
30 
35 
40 
45 
50 
55 
60 
65 
70 
75 
80 
85 
90 
95 
100 
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
 
967.48 
690.33 
463.21 
749.37 
708.34 
545.27 
m/z 
[M+Na]+ 
Y3 
Y3 
B3 
B3 
Y2 
Y2 
300.24 
Y1 
Y1 
B2 
B2 B1 
241.09 
B1 
C2 
C2 
C3 
C3 
445.24 259.13 
C1 
C1 
200 250 300 350 400 450 500 550 600 650 700 750 800 850 900 950 
m/z 
0 
5 
10 
15 
20 
25 
30 
35 
40 
45 
50 
55 
60 
65 
70 
75 
80 
85 
90 
95 
100 
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
 
967.67 
504.24 
259.12 
708.34 
Y2Į 
Y2Į 
Y1ȕ 
Y1ȕ 
731.36 
749.37 
690.33 
Y1Į 
Y1Į 
B1Į 
C1ȕ 
967 48 
[M+Na]+ 
C1ȕ 
282.24 
B1Į 
B1ȕ 
B1ȕ 
241.13 
486.23 
B2Į 
B2Į 
G2Į 
G2Į 
G1ȕ 
G1ȕ 
667.31 
C1Į 
C1Į 
 12 
 
 
 
 
 
 
 
Figure S- 5. HCD spectra of precursor m/z 1141, [M + Na]+ from porcine urothelial N-
glycans (top) and O-glycans (bottom). 
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Figure S- 6. HCD spectra of precursor m/z 1171, [M + Na]+ from porcine urothelial N-
glycans (top) and O-glycans (bottom). 
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Figure S- 7. MALDI-FT-ICR mass spectrum of permethylation O-glycans, released from a) 
Y101 and b) Y201 MSC cell lines. All glycans ionised as [M + Na]+. 
 
Table S- 3. List of O-glycans identified from Y201 and Y101 MSC cell lines, showing mass 
accuracy. 
glycan  
composition 
calculated 
m/z 
Y201 WT 
average 
measured 
m/z (n=5) 
Y201 WT  
mass 
accuracy 
(ppm) 
Y101 WT 
average 
measured 
m/z (n=5)  
Y101 WT  
mass 
accuracy 
(ppm) 
Hex1HexNAc1 518.2572 518.2571 -0.12 518.2570 -0.41 
Hex2HexNAc1 722.3569 722.3568 -0.19 722.3567 -0.32 
Hex1HexNAc1NeuAc1 879.4304 879.4301 -0.40 879.4304 0.05 
Hex3HexNAc1 
926.4567 
 
926.4559 
 -0.87 - - 
Hex2HexNAc2 967.4833 967.4826 -0.72 967.4826 -0.75 
Hex2HexNAc1NeuAc1 1083.5306 1083.5299 -0.63 1083.5307 0.12 
Hex2HexNAc2Fuc1 1141.5725 1141.5714 -0.95 1141.5744 1.64 
Hex3HexNAc2 1171.5831  - -  1171.5830 -0.12 
Hex1HexNAc1NeuAc2 1240.6045 1240.6034 -0.88 1240.6032 -1.04 
Hex2HexNAc2NeuAc1 1328.6569 1328.6535 -2.53 1328.6561 -0.59 
Hex3HexNAc2Fuc1 1345.6723 1345.6726 -0.22 - - 
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Figure S-8.  MALDI-FT-ICR mass spectrum of permethylated O-glycans, released 
from Y101 Cog4KD MSCs. All glycans ionised as [M + Na]+. 
 
 
Table S- 4. List of O-glycans identified in Y101 Cog4KD MSC cell line, along with their mass 
accuracies. 
glycan  
composition 
calculated 
m/z 
Y101 Cog4KD 
(av. 
measured 
m/z, n = 5) 
Y101 Cog4KD 
mass accuracy 
(ppm) 
Hex1HexNAc1 518.2572 518.2571 -0.28 
Hex2HexNAc1 722.3569 722.3568 -0.15 
Hex1HexNAc1NeuAc1 879.4304 879.4303 -0.11 
Hex2HexNAc2 967.4833 967.4827 -0.58 
Hex2HexNAc2Fuc1 1141.5725 - - 
Hex3HexNAc2 1171.5831 - - 
Hex2HexNAc2NeuAc1 1328.6569 1328.6559 -0.76 
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Figure S-9. Comparison of N-glycan profiles of the Y101 wild-type MSCs 
with Cog4KD MSCs. Relative abundance calculated by calculating each 
glycan signal as a percentage of the spiked internal standard signal. 
 
